Skip to main content
. 2024 Jun 5;310(1):577–586. doi: 10.1007/s00404-024-07511-4
Our study reveals a noteworthy increase in gynaecologic cancer surgery waiting times and significant disruptions to ongoing gynaecologic oncology clinical trials during the COVID-19 pandemic. Our findings underscore the widespread impact on clinical research, emphasizing the need for adaptive strategies in healthcare practices among gynaecologic oncology community.